P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 18 December 2014 | 3:09 pm

You are here

Home » News & Media » Press Releases » Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation as a Treatment for more ...

Published 18 December 2014 | 2:48 pm

Pivotal phase III study of GSK shingles candidate vaccine meets its primary endpoint

GSK today announced that a pivotal phase III study to assess the efficacy of HZ/su, an investigational vaccine for the prevention of shingles, has met its primary endpoint. more ...

Published 18 December 2014 | 8:08 am

LynparzaTMapproved in the European Union as first-in-class treatment for advanced BRCA-mutated ovarian cancer

AstraZeneca today announced that the European Commission (EC) has granted Marketing Authorisation for LynparzaTM (olaparib) capsules (400mg twice daily) as the first more ...

Published 17 December 2014 | 6:25 pm

Lilly Sets Dates and Conference Calls for 2015 Financial Guidance and Fourth-Quarter 2014 Financial Results

INDIANAPOLIS, Dec. 17, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2015 on Wednesday, January 7, 2015 and, separately, more ...

Published 17 December 2014 | 4:43 pm

Bristol-Myers Squibb Earns 'Best of Green Schools 2014' Award for Efforts to Help New Jersey's Schools Become More Sustainable

Bristol-Myers Squibb is one of 10 Best of Green Schools award winners for 2014 selected by the U.S. Green Building Council's (USGBC) Center for Green Schools. The award more ...

Published 17 December 2014 | 3:22 pm

Pfizer Initiates Phase 2 Study of PF-06252616 in Duchenne Muscular Dystrophy

Wednesday, December 17, 2014 - 8:00am EST Pfizer Inc. (NYSE:PFE) announced today enrollment of the first patient in a multicenter Phase II clinical trial of the more ...

Published 17 December 2014 | 7:03 am

Merial acquires two major equine health products from Bayer

today announced that Merial, its animal health company, has reached an agreement with Bayer HealthCare to purchase two Bayer equine health products, Legend more ...

Published 16 December 2014 | 8:54 pm

Lilly's CYRAMZA® (ramucirumab) Receives Third FDA Approval

CYRAMZA is the first treatment approved in the U.S. for use in combination with docetaxel in second-line metastatic non-small cell lung cancer more ...

Published 16 December 2014 | 4:32 pm

How common is epilepsy?

Posted by Amy Chandler, Public Relations & Communications UCB, Inc. 16-Dec-2014 more ...

Published 16 December 2014 | 4:27 pm

How common is epilepsy?

Posted by Amy Chandler, Public Relations & Communications UCB, Inc. 16-Dec-2014 more ...

Pharma Documentation Ring:
23 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Sept 22-25, 2015 – Zuerich/Switzerland

Next Annual General Meeting, Sept 22-25, 2015 – Zuerich/Switzerland

Foto: © MadGeographer